Abstract
One new neolignan, racelactone A (1), together with seven known compounds (2−8) were isolated from the methanolic extract of the leaves and twigs of Lumnitzera racemosa. The structure of racelactone A (1) was determined on the basis of the mass and NMR spectroscopic data interpretation. With respect to bioactivity, compound 1 displayed an anti-angiogenic effect by suppressing tube formation. Furthermore, compounds 1, 4, and 5 showed significant anti-inflammatory effects with IC50 values of 4.95 ± 0.89, 1.95 ± 0.40, and 2.57 ± 0.23 µM, respectively. The plausible biosynthesis pathway of racelactone A (1) was proposed.
| Original language | English |
|---|---|
| Article number | 404 |
| Journal | Marine Drugs |
| Volume | 16 |
| Issue number | 11 |
| DOIs | |
| State | Published - 25 10 2018 |
Bibliographical note
Publisher Copyright:© 2018 by the authors.
Keywords
- Anti-angiogenesis
- Anti-inflammation
- Lumnitzera racemosa
- Neolignan